Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Mol Neurobiol. 2019 Jul 6;56(12):8589–8602. doi: 10.1007/s12035-019-01691-w

Table 2:

Antibodies used in the study.

Antibody Cat. # Company Dilution Experiment
Arginase 2 SC-20151 Santa Cruz, Dallas, TX 1:500 Western blotting
Brn3a SC-31984 Santa Cruz, Dallas, TX 1:200 Immunostaining
GFAP Z0334 Dako, Carpinteria, CA 1:200 Immunostaining
Iba1 019-19741 Wako, Richmond, VA 1:200 Immunostaining
NeuN MAB377 Millipore, Billerica, MA 1:200 Immunostaining
p-BAD 4366 Cell Signaling, Danvers, MA 1:500 Western blotting
p-ERK1/2 4370 Cell Signaling, Danvers, MA 1:500 Western blotting
total ERK1/2 4695 Cell Signaling, Danvers, MA 1:500 Western blotting
Synaptophysin MABN1193 Millipore, Billerica, MA 1:200 Immunostaining
Tuj1 801202 BioLegend, San Diego, CA 1:200 Immunostaining
β-actin 4511 Sigma-Aldrich, St. Louis, MO 1:5000 Western blotting
Calbindin C9848 Sigma-Aldrich, St. Louis, MO 1: 200 Immunostaining
ChAT AB144P Millipore, Billerica, MA 1:200 Immunostaining
NLRP3 15101 Cell Signaling, Danvers, MA 1:500 Western blotting
Cleaved caspase-1 SC-514 Santa Cruz, Dallas, TX 1:500 Western blotting
p-NFkB 3033 Cell Signaling, Danvers, MA 1:500 Western blotting